SPASFON, coated tablet 30 tablets
Active ingredients: 1,3,5-trimethoxybenzene, Anhydrous phloroglucinol, Phloroglucinol dihydrate
Commercialized according to BDPM
Coated tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SPASFON, comprimé enrobé
- Pharmaceutical form
- comprimé enrobé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC-aluminium de 30 comprimé(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 15%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Douleurs liées à des troubles fonctionnels intestinaux<br>- Spasmes douloureux aiguës des voies urinaires : coliques néphrétiques<br>- Spasmes douloureux gynécologiques<br>- Spasmes douloureux au cours de la grossesse ; JOURNAL OFFICIEL ; 13/06/13
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Mar 1964
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68081368CIP73098608CIP133400930986080Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PHLOROGLUCINOL HYDRATÉcomprimé | 80,000 mg · un comprimé | SA |
| PHLOROGLUCINOL (TRIMÉTHYL ÉTHER DU)comprimé | 80,000 mg · un comprimé | SA |
| PHLOROGLUCINOL ANHYDREcomprimé | 62,233 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.